-
Something wrong with this record ?
Low leptin concentration may identify heart failure patients with central sleep apnea
I. Cundrle, VK. Somers, P. Singh, BD. Johnson, CG. Scott, LJ. Olson,
Language English Country Great Britain
Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Grant support
R01 HL065176
NHLBI NIH HHS - United States
R01 HL071478
NHLBI NIH HHS - United States
UL1 RR024150
NCRR NIH HHS - United States
NLK
Free Medical Journals
from 1992 to 1 year ago
Wiley Free Content
from 1997 to 1 year ago
PubMed
28643476
DOI
10.1111/jsr.12574
Knihovny.cz E-resources
- MeSH
- Biomarkers blood MeSH
- Leptin blood MeSH
- Middle Aged MeSH
- Humans MeSH
- Polysomnography methods MeSH
- Prospective Studies MeSH
- Aged MeSH
- Sleep Apnea, Central blood diagnostic imaging epidemiology MeSH
- Heart Failure blood diagnostic imaging epidemiology MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, N.I.H., Extramural MeSH
Low leptin concentration has been shown to be associated with central sleep apnea in heart failure patients. We hypothesized that low leptin concentration predicts central sleep apnea. Consecutive ambulatory New York Heart Association (NYHA) classes I-IV heart failure patients were studied prospectively, including measurement of serum leptin, echocardiography and polysomnography. Sleep apnea was defined by type (central/mixed/obstructive) and by apnea-hypopnea index ≥5 by polysomnography. Subjects were divided into four groups by polysomnography: (1) central sleep apnea, (2) mixed apnea, (3) no apnea and (4) obstructive sleep apnea. Fifty-six subjects were included. Eighteen subjects were diagnosed with central sleep apnea, 15 with mixed apnea, 12 with obstructive apnea and 11 with no sleep apnea. Leptin concentration was significantly lower in central sleep apnea compared to obstructive apnea (8 ± 10.7 ng mL-1 versus 19.7 ± 14.7 ng mL-1 , P ˂ 0.01) or no sleep apnea (8 ± 10.7 ng mL-1 versus 17.1 ± 8.4 ng mL-1 , P ˂ 0.01). Logistic regression showed leptin to be associated independently with central sleep apnea [odds ratio (OR): 0.19; 95% confidence interval (CI): 0.06-0.62; area under the curve (AUC): 0.80, P < 0.01]. For the detection of central sleep apnea, a cut-off value for leptin concentration 5 ng mL-1 yielded a sensitivity of 50% and specificity of 89%. In conclusion, a low leptin concentration may have utility for the screening of heart failure patients for central sleep apnea.
Department of Biomedical Statistics and Informatics Mayo Clinic Rochester MN USA
Division of Cardiovascular Diseases Mayo Clinic Rochester MN USA
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045607
- 003
- CZ-PrNML
- 005
- 20200115091552.0
- 007
- ta
- 008
- 200109s2018 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/jsr.12574 $2 doi
- 035 __
- $a (PubMed)28643476
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Cundrle, Ivan $u International Clinical Research Center and Department of Anesthesiology and Intensive Care, St. Anne's University Hospital, Brno, Czech Republic.
- 245 10
- $a Low leptin concentration may identify heart failure patients with central sleep apnea / $c I. Cundrle, VK. Somers, P. Singh, BD. Johnson, CG. Scott, LJ. Olson,
- 520 9_
- $a Low leptin concentration has been shown to be associated with central sleep apnea in heart failure patients. We hypothesized that low leptin concentration predicts central sleep apnea. Consecutive ambulatory New York Heart Association (NYHA) classes I-IV heart failure patients were studied prospectively, including measurement of serum leptin, echocardiography and polysomnography. Sleep apnea was defined by type (central/mixed/obstructive) and by apnea-hypopnea index ≥5 by polysomnography. Subjects were divided into four groups by polysomnography: (1) central sleep apnea, (2) mixed apnea, (3) no apnea and (4) obstructive sleep apnea. Fifty-six subjects were included. Eighteen subjects were diagnosed with central sleep apnea, 15 with mixed apnea, 12 with obstructive apnea and 11 with no sleep apnea. Leptin concentration was significantly lower in central sleep apnea compared to obstructive apnea (8 ± 10.7 ng mL-1 versus 19.7 ± 14.7 ng mL-1 , P ˂ 0.01) or no sleep apnea (8 ± 10.7 ng mL-1 versus 17.1 ± 8.4 ng mL-1 , P ˂ 0.01). Logistic regression showed leptin to be associated independently with central sleep apnea [odds ratio (OR): 0.19; 95% confidence interval (CI): 0.06-0.62; area under the curve (AUC): 0.80, P < 0.01]. For the detection of central sleep apnea, a cut-off value for leptin concentration 5 ng mL-1 yielded a sensitivity of 50% and specificity of 89%. In conclusion, a low leptin concentration may have utility for the screening of heart failure patients for central sleep apnea.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a srdeční selhání $x krev $x diagnostické zobrazování $x epidemiologie $7 D006333
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a leptin $x krev $7 D020738
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a polysomnografie $x metody $7 D017286
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a spánková apnoe centrální $x krev $x diagnostické zobrazování $x epidemiologie $7 D020182
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Somers, Virend K $u Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
- 700 1_
- $a Singh, Prachi $u Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
- 700 1_
- $a Johnson, Bruce D $u Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
- 700 1_
- $a Scott, Christopher G $u Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
- 700 1_
- $a Olson, Lyle J $u Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
- 773 0_
- $w MED00002940 $t Journal of sleep research $x 1365-2869 $g Roč. 27, č. 2 (2018), s. 240-243
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28643476 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200115091925 $b ABA008
- 999 __
- $a ok $b bmc $g 1483875 $s 1084280
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 27 $c 2 $d 240-243 $e 20170623 $i 1365-2869 $m Journal of sleep research $n J Sleep Res $x MED00002940
- GRA __
- $a R01 HL065176 $p NHLBI NIH HHS $2 United States
- GRA __
- $a R01 HL071478 $p NHLBI NIH HHS $2 United States
- GRA __
- $a UL1 RR024150 $p NCRR NIH HHS $2 United States
- LZP __
- $a Pubmed-20200109